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OBJECTIVES We present the remodeling index (RI) versus serial intravascular ultrasound (IVUS) data.
BACKGROUND The RI, derived by comparing lesion external elastic membrane (EEM) cross-sectional area
versus the reference at one time point, is used in various IVUS studies as a substitute of true
remodeling (change in EEM over time), assuming that it represents true remodeling.
METHODS We studied 46 non-stenotic left main arteries using serial IVUS (follow-up 18  8 months).
Plaques were divided into subgroups according to the follow-up RI: follow-up RI 1 (n 
27) versus follow-up RI 1 (n  19).
RESULTS Lesions with a follow-up RI 1 had an increase in lumen despite an increase in plaque
because of an increase in EEM. Conversely, lesions with a follow-up RI 1 had a reduction
in lumen as a result of both a plaque increase and EEM decrease. Overall, the follow-up RI
correlated directly with changes in lesion site EEM (baseline-to-follow-up). Although there
was no correlation between the follow-up RI and changes in reference EEM area, changes in
reference EEM area did correlate directly with changes in lesion EEM area. In nearly 90%
of lesions with a follow-up RI 1, there was a previously documented increase in EEM area.
Using multivariate linear regression analysis, the follow-up RI was dependent on the baseline
RI, the increase in lesion EEM area, and the decrease in reference EEM area. The follow-up
RI was not dependent on changes in lesion plaque area.
CONCLUSIONS The vast majority of left main lesions with a remodeling index 1 had evidence of a previous
increase in lesion-site EEM area. (J Am Coll Cardiol 2006;47:1363–8) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.055American College of Cardiology Foundation
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qoth histopathologic (1–3) and intravascular ultrasound
IVUS) analyses (3–12) have described positive and negative
emodeling of atherosclerotic lesions, typically by compar-
ng absolute lesion-site external elastic membrane (EEM)
easurements to the reference segments at a single point in
ime. For example, a remodeling index (RI) can be derived
s lesion-site EEM cross-sectional area (CSA) divided by a
re-defined reference vessel area; RI 1 is considered
vidence for positive remodeling, whereas RI 1 suggests
ntermediate or negative remodeling. However, for many
easons (such as single time-point observation as well as
eference segment selection, tapering, plaque burden, and
emodeling), these indexes are acknowledged to be only
ndirect evidence of remodeling (13,14). Direct evidence of
From the *Medisch Spectrum Twente, Department of Cardiology, Enschede, the
etherlands; †Essen University, Department of Cardiology, Essen, Germany; and the
Cardiovascular Research Foundation, New York, New York.m
Manuscript received July 28, 2005; revised manuscript received October 26, 2005,
ccepted November 8, 2005.emodeling requires serial EEM measurements obtained at
wo (or more) time points (15–19).
In the present serial IVUS study in non-stenotic left main
oronary lesions, we assessed whether the more commonly
sed indirect assessment of remodeling (i.e., the RI) reflects
rue vascular remodeling (i.e., changes in lesion-site EEM
SA). Therefore, we compared the RI at follow-up with
he preceding changes in vessel dimensions.
ETHODS
tudy population. We analyzed serial IVUS data of 46
atients who had hemodynamically non-significant de novo
eft main atherosclerotic lesions and reliable reference seg-
ents; these patients were from a population of 60 lesions
hat has previously been reported (18,19). Fourteen left
ain lesions were excluded because there was a lack of a
ell-defined reference (14).
All patients met the following criteria: 1) serial high-
uality IVUS imaging of the entire left main stem 12
onths apart; 2) calcifications that did not limit the
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Remodeling Index Versus Serial Remodeling April 4, 2006:1363–8uantitative assessment of vessel area (shadowing 75° of
he adventitial circumference by individual calcific deposits);
) non-ostial target site location; 4) angiographic lumen
iameter stenosis 30% (“worst view” visual assessment);
) no intervention in the very proximal left anterior de-
cending or circumflex coronary artery segments because
hese interventions could have affected the left main artery;
nd 6) well-defined lesion and reference image slices.
atients were examined in the Essen University Cardiac
atheterization Laboratory with a follow-up of 17.7  8.1
onths (median 15 months, range 12 to 49 months). As
reviously reported, this represents a consecutive series of
atients who underwent initial IVUS examination during
oronary intervention and then returned after 1 year for
epeat intervention during which another IVUS study was
erformed (18). The IVUS study was approved by the local
ouncil on human research. All patients signed a written
nformed consent form as approved by the local medical
thics committee.
emographics, medications, and lipid status. Demo-
raphics including cardiovascular risk factors, medications,
nd the lipid status were prospectively recorded in our
aboratory including diabetes mellitus and hypertension
both medication-dependent only); hypercholesterolemia
medication-dependent, total serum cholesterol 200 mg/
l, or low-density lipoprotein cholesterol 160 mg/dl);
istory of smoking; and family history of coronary artery
isease. Data of laboratory tests were means of the baseline
nd follow-up values. Medications were recorded only if
rugs were taken for 50% of the follow-up interval (e.g.,
lopidogrel for four weeks was not tabulated). Plasma
oncentrations of total cholesterol, low-density lipoprotein
holesterol, high-density lipoprotein cholesterol, and tri-
lycerides were measured by standard enzymatic methods.
VUS imaging. Intravascular ultrasound was performed as
reviously described (18). In brief, IVUS studies were
erformed during percutaneous coronary interventions of
id- or distal left anterior or left circumflex arteries after
ntracoronary injections of 200 g nitroglycerin. Two com-
ercial systems were used: a mechanical sector scanner
Boston Scientific Corporation, San Jose, California) incor-
orating a 30-MHz single-element beveled transducer or a
olid-state device (Endosonics, Rancho Cordova, Califor-
ia). Importantly, at Essen University, if a patient under-
oes imaging with one IVUS system during an index
rocedure, the same IVUS system is used at follow-up. Slow
ontinuous pullbacks of the IVUS transducer were started as
Abbreviations and Acronyms
CSA  cross-sectional area
EEM  external elastic membrane
IVUS  intravascular ultrasound
P&M  plaque and media
RI  remodeling indexistal as possible in one of the left coronary arteries and were (enerally performed using a motorized pullback device (at
.5 mm/s); IVUS images of the entire pullback were
ecorded on 0.5-inch high-resolution s-VHS tape for off-
ine analysis. In addition, a dedicated image-in-image sys-
em (Echo-Map, Siemens, Erlangen, Germany) (20) was
sed to record the “angiographic” position of the IVUS
robe together with the corresponding IVUS image—
specially at sites of characteristic landmarks (i.e., calcifications
r unusual plaque shapes) and/or the target site. Follow-up
VUS studies were performed (using the same IVUS system as
nitially) during repeat coronary interventions or during
VUS examinations of ambiguous left coronary lesions or
clinically driven) follow-up catheterizations.
uantitative IVUS analysis. The target lesion site image
lice was the slice with the smallest lumen CSA (18). If
here were several slices with equal lumen size, the one with
he largest EEM and plaque and media (P&M  EEM 
umen) CSA was analyzed (6,14). A left main stem refer-
nce image slice was selected as the most normal-looking
ross section (largest lumen with smallest P&M) distal or
roximal to the target lesion. Exact matching of the initial
nd follow-up IVUS studies was ensured using side-by-side
omparison of the serial IVUS video sequences along with
nformation of the pullback speed (18); the operators’ recorded
omments (on videotape); and characteristic calcifications,
ascular and perivascular landmarks, and plaque shapes. If
equired, the X-ray sequences of the dedicated image-in-
mage system (Echo-Map) were revisited to optimize
atching (18,20).
The lumen CSA was measured by tracing the leading
dge of the intima. The EEM CSA was measured by
racing the leading edge of the adventitia. As in many
revious IVUS studies, P&M was used as a measure of
therosclerotic plaque because IVUS cannot measure media
hickness accurately. Lumen and plaque eccentricity ([max-
mum lumen/plaque diameter minus minimum lumen/
laque diameter] divided by maximum lumen/plaque diam-
ter) was calculated. In our laboratory, the intraclass correlation
oefficient is 0.99 for repeated measurements of EEM, 0.96
or lumen, and 0.99 for P&M CSA.
We calculated the changes between () the initial and
ollow-up IVUS data. To compensate for the variation in
ollow-up interval and to obtain comparable data, measure-
ents were normalized for the length of the follow-up
eriod and annual changes (i.e., changes per year) were
eported and compared.
irect (serial IVUS) measurement of arterial remodeling
nd RI. The change in lesion-site EEM CSA was the
irect measure of arterial remodeling (i.e., serial arterial
emodeling or “remodeling behavior”). The RI was calcu-
ated at follow-up as lesion site divided by reference EEM
SA (13,14) and used to classify lesions into positive
emodeling (RI 1) and intermediate/negative remodeling
RI 1).
tatistics. Analyses were performed with SPSS 10.0.7
Microsoft, Redmond, Washington) and MedCalc (version
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April 4, 2006:1363–8 Remodeling Index Versus Serial Remodeling.16, Mariakerke, Belgium) software packages for Win-
ows. Dichotomous data are presented as frequencies and
ompared using chi-square statistics; Fisher exact test was
pplied if at least one expected frequency was 5. Quanti-
ative data are presented as mean values  1 SD and
ompared using Student t test and linear regression analysis.
value of p  0.05 was considered significant.
ESULTS
tudy population. Plaques were divided into two groups
ccording to the follow-up RI: follow-up RI 1 (n  27)
ersus RI 1 (n  19). The actual RI values were 1.15 
.16 and 0.89  0.09, respectively (p  0.0001). There was
o difference in demographics, medication, and lipid status
etween the two groups (Table 1).
ollow-up IVUS remodeling. In lesions with a follow-up
I 1, baseline reference EEM and lumen CSA were
maller and baseline RI was larger compared to lesions with
able 1. Patient Demographics, Medication, and Lipid Status
Follow-Up
RI >1
(n  27)
Follow-Up
RI <1
(n  19)
p
Value
ime of follow-up (months) 17.9  7.1 17.4  9.6 0.8
ge (yrs) 59  9 57  9 0.5
en 24 (89%) 17 (89%) 1.0*
ody mass index (kg/m2) 27  3 26  3 0.3
ypercholesterolemia 25 (93%) 16 (84%) 0.6*
ystemic arterial hypertension 21 (78%) 13 (68%) 0.5*
iabetes mellitus 5 (19%) 1 (5%) 0.4*
moker 10 (37%) 5 (26%) 0.7†
amily history of coronary disease 6 (22%) 4 (21%) 1.0*
revious myocardial infarction 10 (37%) 4 (21%) 0.3*
vessel narrowed 50% 10 (37%) 10 (53%) 0.5†
vessels narrowed 50% 9 (33%) 4 (21%) 0.5*
vessels narrowed 50% 8 (30%) 5 (26%) 0.9†
table angina CCS class I 8 (30%) 7 (37%) 0.8†
table angina CCS class II 10 (37%) 8 (42%) 1.0†
table angina CCS class III 6 (22%) 3 (16%) 0.7*
nstable angina 3 (11%) 1 (5%) 0.6*
edication
Acetylsalicylic acid 27 (100%) 19 (100%) 1.0*
ACE inhibitors 9 (33%) 9 (47%) 0.5†
Angiotensin receptor antagonists 1 (4%) 0 (0%) 1.0*
Beta-blockers 15 (56%) 9 (47%) 0.8†
Calcium-channel blockers 11 (41%) 4 (21%) 0.2*
Diuretics 10 (37%) 3 (16%) 0.2*
Fibrates 2 (7%) 1 (5%) 1.0*
Insulin 1 (4%) 0 (0%) 1.0*
Nitrates 19 (70%) 10 (53%) 0.4†
Oral antidiabetics 2 (7%) 1 (5%) 1.0*
Statins 22 (81%) 14 (74%) 0.7*
ipid status‡
Total cholesterol (mg/dl) 196  37 189  37 0.5
LDL cholesterol (mg/dl) 123  46 115  43 0.6
HDL cholesterol (mg/dl) 48  16 47  10 0.8
Triglycerides (mg/dl) 128  71 123  65 0.8
Compared using Fisher exact test; †compared using chi-square statistics; ‡data of
aboratory tests are mean values of measurements obtained at time of initial and
ollow-up intravascular ultrasound examinations.ACE  angiotensin-converting enzyme; HDL  high-density lipoprotein;
DL  low-density lipoprotein; RI  remodeling index.
vfollow-up RI 1 (Table 2). The other baseline IVUS
easurements—reference P&M CSA and lesion EEM,
umen, and P&M CSA as well as lesion plaque burden—
ere similar between the two groups.
We then analyzed the baseline-to-follow-up changes
n IVUS measurements in patients with follow-up left
ain stem RI 1 versus follow-up RI 1 (Table 3).
hanges in reference segment EEM, lumen, and P&M
SA measurements were similar between the two groups.
he two groups had similar increases in lesion P&M
SA from baseline to follow-up. However, lesions with a
ollow-up RI 1 had an increase in minimum lumen
SA despite this increase in P&M CSA; this was the
able 2. Comparison of the Baseline IVUS Data According to
ollow-Up Remodeling Index
Follow-Up
RI >1
(n  27)
Follow-Up
RI <1
(n  19)
p
Value
aseline reference
EEM CSA (mm2) 22.4  5.8 27.4  8.0 <0.02
Lumen CSA (mm2) 16.8  3.4 21.7  6.9 <0.01
P&M CSA (mm2) 5.7  4.1 5.7  2.2 0.9
Plaque burden (%) 23.0  11.3 21.1  7.1 0.5
aseline lesion
EEM CSA (mm2) 24.3  5.1* 25.7  6.2† 0.4
Lumen CSA (mm2) 15.1  3.1* 16.1  4.9‡ 0.4
P&M CSA (mm2) 9.3  4.0‡ 9.6  3.1‡ 0.8
Plaque burden (%) 37.2  10.9‡ 37.8  9.3‡ 0.8
Lumen eccentricity 0.18  0.10 0.18  0.11 1.0
Plaque eccentricity 0.76  0.11 0.79  0.09 0.3
aseline RI 1.11  0.17 0.96  0.11 <0.001
eference vs. lesion: *p  0.01, †p  0.05, ‡p  0.001. Bold values indicate
ignificant p values.
CSA  cross-sectional area; EEM  external elastic membrane; IVUS 
ntravascular ultrasound; P&M  plaque and media; RI  remodeling index.
able 3. Comparison of the Serial IVUS Data According to
ollow-Up Remodeling Index
Follow-Up
RI >1
(n  27)
Follow-Up
RI <1
(n  19)
p
Value
eference changes
EEM CSA/yr (mm2) 0.9  3.0 1.0  5.0 0.9
EEM CSA/yr (%) 5.8  16.2 7.1  21.8 0.8
Lumen CSA/yr (mm2) 0.8  2.4 1.1  3.5 0.8
Lumen CSA/yr (%) 6.2  15.4 8.5  20.2 0.7
P&M CSA/yr (mm2) 0.1  1.6* 0.1  2.2 0.8
P&M CSA/yr (%) 8.6  29.5 9.8  48.0 0.9
esion changes
EEM CSA/yr (mm2) 2.0  2.4† 0.7  3.5 <0.0001
EEM CSA/yr (%) 8.4  10.2 1.6  9.6† <0.0001
Lumen CSA/yr (mm2) 1.0  2.7 1.2  1.9* <0.0001
Lumen CSA/yr (%) 8.1  18.5 7.0  11.2* <0.0001
P&M CSA/yr (mm2) 1.0  1.2* 0.6  1.8† 0.5
P&M CSA/yr (%) 15.2  19.2 7.5  18.4 0.2
ocumented prior
serial lesion remodeling
<0.05‡
EEM CSA 0 24 (89%) 11 (58%)
EEM CSA 0 3 (11%) 8 (42%)
eference vs. lesion: *p  0.01; †p  0.05; ‡compared using Fisher exact test. Bold
alues indicate significant p values.
  changes; other abbreviations as in Table 2.
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Remodeling Index Versus Serial Remodeling April 4, 2006:1363–8esult of an increase in lesion EEM CSA. Conversely, on
verage, lesions with a follow-up RI 1 had a reduction
n minimum lumen CSA as a result of both, P&M CSA
ncrease and EEM CSA decrease.
Overall, the follow-up RI correlated directly with
lesion-site EEM CSA (baseline-to-follow-up) (Fig. 1); of
ote, there was a substantial amount of patient-to-patient
ariation. In addition, there was no correlation between
reference EEM CSA and the follow-up RI (y  0.01x
1.05, r  0.16, p  0.15; graph not shown), whereas
reference EEM CSA did correlate directly with lesion
EM CSA (y  0.41x  0.82, r  0.53, p  0.001; graph
ot shown).
Using multivariate linear regression analysis, the
ollow-up RI was dependent on the baseline RI, the increase
n lesion-site EEM CSA, and the decrease in reference
EM CSA. The follow-up RI was not dependent on
hanges in lesion-site P&M CSA.
ollow-up versus baseline RI. There was a significant
inear relationship between the follow-up RI and the base-
ine RI (Fig. 2). In 74% of lesions, the classification of
emodeling as positive or intermediate/negative was similar
t baseline and follow-up (Table 4).
igure 1. Relation between annual changes in vessel dimensions at lesion
ite versus the remodeling index at follow-up. Serial (baseline-to-follow-
p) changes in external elastic membrane (EEM) cross-sectional area
CSA) correlated with the remodeling index at follow-up.o
igure 2. Linear relation between the remodeling index at follow-up versus
he remodeling index at baseline.ISCUSSION
ositive (or outward) remodeling has been postulated to
xplain the finding of atherosclerosis that does not encroach
n the arterial lumen. Remodeling of atherosclerotic human
oronary arteries was described first by Glagov et al. (1)
primarily in non-stenotic reference segments from autop-
ied hearts) by correlating EEM CSA with plaque CSA and
laque burden. The observations by Glagov et al. (1) were
onfirmed in vivo using IVUS (3,4,13). Since then, lesion
emodeling has been most often studied by comparing the
esion to proximal and/or distal reference segments at a
ingle point in time to generate an RI, even though these
eference segments have also remodeled (13). Lesions are
lassified as positive versus intermediate and negative
emodeling based on this comparison (13,14). Although
here are many theoretical limitations to this approach
13), the results of our current serial IVUS study show that
he RI is a relatively good substitute of true vascular
emodeling.
When the baseline-to-follow-up change in EEM CSA
as compared to the follow-up RI, lesions with a follow-up
I 1 had a previously documented increase in EEM in
early 90%. The independent predictors of the follow-up RI
ere the baseline RI, the increase in lesion EEM CSA, and
he decrease in reference EEM CSA. Our study demon-
trates that the classification of a lesion as positive versus
ntermediate/negative remodeling tends to remain relatively
onstant over time. We found a significant linear relation-
hip between the follow-up RI versus the baseline RI, and in
lmost 75% of lesions, the classification was similar at
aseline and after 18 months of follow-up. In particular,
ositively remodeled lesions continued to positively re-
odel.
We found a significant correlation between changes in
esion EEM CSA (serial remodeling) and the follow-up RI.
owever, there was a substantial patient-to-patient varia-
ion (e.g., the RI varied from approximately 0.7 to 1.5 when
n fact there was no serial remodeling) (Fig. 1). Thus, the RI
ay be a very good correlate of true remodeling for a
opulation rather than for an individual lesion.
In addition, our data showed no difference in baseline
laque burden between lesions with positive versus neg-
tive RI, thereby questioning the concept that remodel-
ng occurs until approximately 40% of the artery is
able 4. Comparison of Positive Versus Intermediate/Negative
emodeling Classification at Baseline and Follow-Up
Baseline
RI >1
(n  29)
Baseline
RI <1
(n  17)
p
Value
ollow-up RI 1 (n  19) 7 (24%) 12 (71%) <0.01*
ollow-up RI 1 (n  27) 22 (76%) 5 (29%)
Compared using chi-square statistics. Bold values indicate significant p values.
RI  remodeling index.ccupied by plaque (1).
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April 4, 2006:1363–8 Remodeling Index Versus Serial RemodelingVUS insights into remodeling from previous serial
tudies. Few serial IVUS studies in native coronary arteries
like the present study) have been reported. Such studies
ermit an assessment of remodeling independent of refer-
nce segment changes. Shiran et al. (15) studied 31 left
ain stems to demonstrate that lumen changes during six
onths follow-up resulted primarily from EEM changes
i.e., remodeling). Although the assessment of arterial
emodeling was not the main purpose of the pharmacolog-
cal intervention studies by Takagi et al. (16) and Schartl et
l. (17), the presence of positive remodeling was clearly
emonstrated.
hy study arterial remodeling? Cumulative evidence from
arious studies suggests that positively remodeled lesions are
ore biologically active than intermediate or negatively
emodeled lesions and that they occur in patients who are
ore prone to develop additional unstable lesions or other
orms of clinical instability (21,22). For instance, de novo
oronary lesions in patients with acute coronary syndromes
ore often have positive remodeling characteristics com-
ared with either chronic stable angina lesions or to control
laques elsewhere in the coronary tree (9,10,12,23). In
ddition, positive remodeling was found to be strongly
ssociated with single and multiple plaque ruptures and
hrombus formation in such patients (11,24–26). In the
ontext of percutaneous coronary interventions, positive re-
odeling has been shown to be a predictor of: 1) post-
nterventional creatinine kinase-MB elevation (27); 2) no
eflow after primary infarct angioplasty (28); 3) recurrent
schemia within one month after thrombolysis for acute
yocardial infarction (29); 4) target lesion revascularization
fter non-stent interventions (30); 5) major adverse coronary
vents in patients with unstable angina undergoing percu-
aneous revascularization (31); 6) target vessel revasculariza-
ion and intimal hyperplasia after bare metal stenting
32,33); 7) intimal hyperplasia after implantation of drug-
luting stents (34); and 8) in-hospital complications, major
dverse coronary events, restenosis, and new lesion forma-
ion in patients with stable angina (35).
tudy limitations. By most standards, this was a large
erial IVUS study; however, all long-term serial IVUS
tudies are limited to a relatively small number of patients.
e only studied left main disease as representative of
on-intervened coronary segments; therefore, our findings
ay not be applicable to all (stenotic and non-stenotic)
oronary segments. We only included patients who under-
ent non-left main intervention and who were admitted
or repeat cardiac catheterization 12 months later; thus,
he findings of the current study may not be applicable to
he general population (36). We used two IVUS systems;
lthough this approach may have shortcomings, every
ffort was taken to obtain the most reliable data pos-
ible as previously discussed (18). Three-dimensional
electrocardiogram-gated) IVUS analyses (37) may be su-
erior for the assessment of atherosclerotic coronary arteries
ompared to the two-dimensional analysis used in the
1urrent study. All patients were Caucasian, and most were
en. We only used one classification of remodeling; there
re others that have been reported. Of the 60 patients who
ave been reported previously, only 46 patients could be
ncluded in this analysis because of a lack of a well-defined
eference segment in the other 14 patients. Our data did not
ermit the comparison of different definitions of the RI
38); therefore, our findings may be limited to the definition
sed in the present study.
onclusions. The vast majority of lesions with positive
emodeling classification (RI1) had evidence of a previous
ncrease in lesion-site EEM CSA.
eprint requests and correspondence: Dr. Clemens von Birge-
en, Medisch Spectrum Twente, Thoraxcenter Twente, Cardiol-
gy Department, Haaksbergerstraat 55, 7513 ER Enschede, the
etherlands. E-mail: von.birgelen@12move.nl.
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